ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2421

Patient Treatment Goals in Rheumatoid Arthritis: Results of Focus Groups Among Rheumatologists, English and Spanish-Speaking Patients

Jennifer Barton1, Christopher J. Koenig2, Diana Martinez3, Gina Evans-Young4, Patricia P. Katz1 and Edward H. Yelin5, 1Medicine, University of California, San Francisco, San Francisco, CA, 2Medicine, UCSF, San Francisco, CA, 3UCSF/San Francisco General Hospital, San Francisco, CA, 4Rheumatology, UCSF, San Francisco, CA, 5Arthritis Research Group, University of California, San Francisco, San Francisco, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: goals and objectives, qualitative and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects (ACR): Impact of Various Interventions and Therapeutic Approaches

Session Type: Abstract Submissions (ACR)

Background/Purpose: Treatment guidelines in rheumatoid arthritis (RA) frame provider’s therapeutic goal as disease remission. Although goal concordance between providers and patients has been shown to positively impact outcomes in other chronic diseases, like diabetes, patient-provider goal sharing has not been well-studied in RA.  We performed a literature review and conducted focus groups to identify goals important to RA patients.

Methods: A systematic review using PubMed from 1966 to 2013 included terms for RA and patient goals. The results were used to inform domains discussed in focus groups. We conducted 2 patient focus groups (1 in English, 1 in Spanish), and one with rheumatologists. A professional qualitative researcher conducted the English-language patient and physician groups and trained a bilingual moderator who conducted the Spanish group. We used a two-phase structured process where participants first reflected on personal functional and treatment goals as a way to discuss a wide range of goals. The physician group used a similar process, and included a presentation of goals from patient focus groups. We used Grounded Theory to organize goals thematically and combined patient results with goals identified in the literature review.

Results: 865 papers were identified and after review, 28 articles remained; from these, 110 goals were abstracted. Patient goals from focus groups and literature review fell into one of six categories: symptoms, function/quality of life, treatment, research/policy, social support, and system-level goals. Goals identified by both Spanish and English-speaking patients (Table 1) included symptom goals (less pain), function (ability to open jars), and social support (help family understand severity of disease and what to expect), and treatment (more affordable medications). Areas of difference included goals of improved mood (Spanish), more time with providers (Spanish), more coordination among multiple providers (English), sex and intimacy without shame (English). Providers’ goals included remission, cheap and simple medications, and holistic treatments. Physicians expressed surprise with many of the patient-generated goals, including desire for complementary and alternative medication, and felt overwhelmed and ill-supported to manage mood-related issues.

Conclusion: The elicitation of patient goals and goal setting in RA is an important, understudied area especially among vulnerable populations. More research to study the role of eliciting goals, goal concordance, and its impact on outcomes in diverse populations is needed. Interventions to improve goal concordance may improve self-efficacy, adherence, and outcomes in RA.

 

 

Table. Patient-reported goals organized by themes from focus groups in English (n=7, all female) and Spanish (n=4, 3 females, 1 male)

Themes and individual goals

Both groups

English only

Spanish only

Symptom goals

 

 

 

Less pain

X

Less mobility limitations

X

Improved mood

X

Function/quality of life goals

 

 

 

Ability to open cans and jars (easily)

X

Ability to work consistently/meet expectations

X

Have flare interfere less with activities

X

Being able to exercise safely

X

Transportation / take public transit vs. paratransit / be able to drive

X

Sex and intimacy without shame and/or fear

X

Be able to do housework without “paying the price”

X

Social support goals

 

 

 

Help family understand the severity of the disease and what to expect

X

Social support: Access to support groups/counseling/social workers

X

Would like doctor to ask about emotional well-being, not just physical

X

System-level goals

 

 

 

To find a cure

X

Want more doctor communication around drug treatments and condition

X

More coordination of care between provider types

X

Be understood by their doctor(s)

X

Would like to be able to drink safely (and have more doctor input on subject)

X

Research/policy goals

 

 

 

More access to drugs / more affordable drugs

X

Develop a more sensitive/functional Visual Analog Scale for pain

X

Longer visits to allow for full discussion of RA

X

Treatment goals

 

 

 

More information around nutrition

X

Less surgeries

X

 


Disclosure:

J. Barton,

Pfizer,

2;

C. J. Koenig,
None;

D. Martinez,
None;

G. Evans-Young,
None;

P. P. Katz,
None;

E. H. Yelin,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-treatment-goals-in-rheumatoid-arthritis-results-of-focus-groups-among-rheumatologists-english-and-spanish-speaking-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology